| Financial Year |
March 31 2023 |
| Monetary Funds |
3,181,923,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,910,000.00 |
| Accounts Receivable |
3,186,836,000.00 |
| Advances to Suppliers |
28,066,000.00 |
| Other Receivables |
18,874,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
30,167,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
194,676,000.00 |
| Other Current Assets |
71,151,000.00 |
| Total Current Assets |
6,719,603,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,493,228,000.00 |
| Long-term Equity Investment |
193,108,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
885,208,000.00 |
| Under-construction Projects |
585,827,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,022,685,000.00 |
| R&D expenses |
-- |
| Goodwill |
319,813,000.00 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,354,000.00 |
| Other Non-Current Assets |
433,351,000.00 |
| Sub-Total of Non-Current Assets |
16,949,908,000.00 |
| Total Assets |
23,669,511,000.00 |
| Short-Term Loans |
1,531,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
464,571,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,200,000.00 |
| Taxes Payable |
69,869,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
2,780,000.00 |
| Other payables |
813,957,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,747,279,000.00 |
| Other Current Liabilities |
490,000.00 |
| Sub-Total of Current Liabilities |
3,622,657,000.00 |
| Long-term Loans |
7,310,924,000.00 |
| Bonds Payable |
878,530,000.00 |
| Long-Term Accounts Payable |
154,021,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
85,339,000.00 |
| Other Non-Current Liabilities |
30,000,000.00 |
| Sub-Total of Non-Current Liabilities |
10,302,898,000.00 |
| Total Liabilities |
13,925,555,000.00 |
| Paid-In Capital(Or Share Stock) |
1,570,418,000.00 |
| Capital Surplus |
1,111,156,000.00 |
| Surplus Reserve |
722,389,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,283,446,000.00 |
| Minority Stockholder's Interest |
1,056,547,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,687,409,000.00 |
| Owner's Equity（Stockholder's Equity） |
9,743,956,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,669,511,000.00 |
